Biosenic SA banner

Intrinsic Value

Not Available for BT1

There is not enough data to reliably calculate the intrinsic value for Biosenic SA.

Do our valuations actually work? See backtest results .

Alternatives to BT1

Fundamental Analysis

What Biosenic Does

Biotechnology Health Care

BioSenic SA is a biotech company, which engages in the development of clinical assets. The firm develops cell therapy products for the treatment and regeneration of bone tissue and bone reconstruction applications, osteonecrosis, ununited fractures, and maxillo-facial reconstruction. The company is engaged in research, enable adult stem cell isolation, expansion, and osteogenic differentiation. The Company’s therapeutic area focus is bone diseases, with extensions to joint, mainly osteoarthritis and disc degeneration.

Headquarters
Belgium BE
Employees
3
IPO date
Feb 6, 2015
Read the full company overview
View Company Overview
Financials

Balance Sheet

Efficiency

Wall St Price Targets

Shareholder Returns

Competitive Landscape

Recent Events

Past 12 months

Continue BT1 Research

Decided on Biosenic? Get an email when BT1 reaches the price you’d buy at. Free with an account.

Other Biosenic listings

Back to Top